Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 23,875,816 |
|
|||||
| News | (1) | ||||||
| Day High | 0.9858 | Low High |
|||||
| Day Low | 0.403 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| CERo Therapeutics Holdings Inc | CERO | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.2732 | -38.85% | 0.43 | 15:38:05 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.92 | 0.403 | 0.9858 | 0.7032 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 59,910 | 23,875,816 | $ 0.5014125 | $ 11,971,633 | - | 0.4025 - 12.38 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 15:38:14 | 42 | $ 0.43 | USD |
CERo Therapeutics Holdings Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 6.48M | - | - | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
CERo Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CERO Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.99 | 1.02 | 0.4025 | 0.7456022 | 725,012 | -0.56 | -56.57% |
| 1 Month | 1.14 | 1.17 | 0.4025 | 0.784749 | 227,620 | -0.71 | -62.28% |
| 3 Months | 2.06 | 3.76 | 0.4025 | 2.58 | 683,204 | -1.63 | -79.13% |
| 6 Months | 5.25 | 12.38 | 0.4025 | 2.93 | 890,092 | -4.82 | -91.81% |
| 1 Year | 5.25 | 12.38 | 0.4025 | 2.93 | 890,092 | -4.82 | -91.81% |
| 3 Years | 5.25 | 12.38 | 0.4025 | 2.93 | 890,092 | -4.82 | -91.81% |
| 5 Years | 5.25 | 12.38 | 0.4025 | 2.93 | 890,092 | -4.82 | -91.81% |
CERo Therapeutics Description
| CERo Therapeutics Holdings, Inc. is an immunotherapy company advancing the development of engineered T cell therapeutics for the treatment of cancer. The Company¿s proprietary approach to T cell engineering, enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, which is designed to engage the body¿s full immune repertoire to achieve optimized cancer therapy. Its cellular immunotherapy platform is focused on redirecting patient-derived T cells to eliminate tumors by building in engulfment pathways that employ phagocytic mechanisms to destroy cancer cells, creating CERo, which is referred to as chimeric engulfment receptor t cells (CER-T). The Company is initiating clinical trials for its lead product candidate, CER-1236, for hematological malignancies. |
